146 related articles for article (PubMed ID: 7026021)
1. Eye toxicity of cancer chemotherapy: a review of the literature.
Griffin JD; Garnick MB
Cancer; 1981 Oct; 48(7):1539-49. PubMed ID: 7026021
[No Abstract] [Full Text] [Related]
2. [Ophthalmologic side effects of the use of cytostatic agents].
Zaal MJ; Polak BC
Ned Tijdschr Geneeskd; 1985 Oct; 129(40):1919-21. PubMed ID: 4069251
[No Abstract] [Full Text] [Related]
3. Ocular side effects of cancer chemotherapy.
Vizel M; Oster MW
Cancer; 1982 May; 49(10):1999-2002. PubMed ID: 7074524
[TBL] [Abstract][Full Text] [Related]
4. [Cardiac toxicity of vinca alkaloids. Critical review of the literature].
Aymard JP; Ferry R; Netter P; Balaud A; Streiff F
Therapie; 1985; 40(5):361-4. PubMed ID: 3913049
[No Abstract] [Full Text] [Related]
5. Neurotoxicity in cancer chemotherapy: vinca alkaloids.
Lobert S
Crit Care Nurse; 1997 Aug; 17(4):71-9. PubMed ID: 9325775
[No Abstract] [Full Text] [Related]
6. Neurotoxicity secondary to antineoplastic drugs.
Tuxen MK; Hansen SW
Cancer Treat Rev; 1994 Apr; 20(2):191-214. PubMed ID: 8156541
[No Abstract] [Full Text] [Related]
7. Ocular toxicity of antineoplastic agents.
Fraunfelder FT; Meyer SM
Ophthalmology; 1983 Jan; 90(1):1-3. PubMed ID: 6828303
[TBL] [Abstract][Full Text] [Related]
8. Dacryoscintigraphy for the detection of ocular drainage system stenosis induced by docetaxel and fluorouracil.
Tsoucalas GI; Tzovaras AA; Ntokou AP; Markos LI; Sarafianou EN
Hell J Nucl Med; 2012; 15(2):159-61. PubMed ID: 22741155
[No Abstract] [Full Text] [Related]
9. Cancer chemotherapy. 4. Those dreaded side effects and what to do about them.
Levitt DZ
RN; 1980 Dec; 43(12):33-7, 112. PubMed ID: 6905240
[No Abstract] [Full Text] [Related]
10. Drug interactions with antineoplastic agents.
Warren RD; Bender RA
Cancer Treat Rep; 1977 Oct; 61(7):1231-41. PubMed ID: 589593
[No Abstract] [Full Text] [Related]
11. DRUGS OF CURRENT USE FOR THE TREATMENT OF CANCER AND ALLIED DISEASES.
GOLDENBERG DM
Dis Chest; 1963 Dec; 51():191-208. PubMed ID: 14102116
[No Abstract] [Full Text] [Related]
12. [Drugs and the eye].
Hoang-Xuan T; Bouder P
Rev Prat; 1994 Feb; 44(3):415-8. PubMed ID: 7909955
[No Abstract] [Full Text] [Related]
13. Effects of cancer, radiotherapy and cytotoxic drugs on intestinal structure and function.
Shaw MT; Spector MH; Ladman AJ
Cancer Treat Rev; 1979 Sep; 6(3):141-51. PubMed ID: 394833
[No Abstract] [Full Text] [Related]
14. [Toxic effects of cytostatic agents on the lung in monochemotherapy and polychemotherapy].
Renovanz HD
Wien Med Wochenschr; 1983 Apr; 133(7):159-67. PubMed ID: 6868616
[No Abstract] [Full Text] [Related]
15. Ocular complications of systemic cancer chemotherapy.
Imperia PS; Lazarus HM; Lass JH
Surv Ophthalmol; 1989; 34(3):209-30. PubMed ID: 2694416
[TBL] [Abstract][Full Text] [Related]
16. [Current trends in the chemotherapy of cancer].
Silva-Sosa M
Gac Med Mex; 1974 May; 107(5):469-87. PubMed ID: 4602758
[No Abstract] [Full Text] [Related]
17. Iatrogenic eye disease.
Cant JS
Practitioner; 1969 Jun; 202(212):787-95. PubMed ID: 5796539
[No Abstract] [Full Text] [Related]
18. [Hepatic complications of chemotherapy. From trivial cytolysis to hepatic veno-occlusive disease].
Baron F; Beguin Y
Rev Med Liege; 1997 Feb; 52(2):93-7. PubMed ID: 9173491
[No Abstract] [Full Text] [Related]
19. Chemotherapy-induced peripheral neuropathy: A need for standardization in measurement.
Dunlap B; Paice JA
J Support Oncol; 2006 Sep; 4(8):398-9. PubMed ID: 17004514
[No Abstract] [Full Text] [Related]
20. Delayed consequences of cancer therapy: proven and potential. Basic mechanisms.
Cancer; 1976 Feb; 37(2 Suppl):999-1013. PubMed ID: 1253134
[No Abstract] [Full Text] [Related]
[Next] [New Search]